TrialPloS one2024

The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.

Julia König et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.